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Abstract 
Blood flow in the plantar hindpaw skin of anaesthetized ratswas measured by Iaser Doppler flowmetry. Intraplantar injection 
of interleukin-lß (50 pg) significantly enhanced the hyperaemic response to intraplantar capsaicin (0.3 ,.,.g). Pretreatment with a 
neurotoxic dose of capsaicin reduced the capsaicin-evoked hyperaemia and prevented the facilitatory effect of interleukin-lß. 
Blockade of nitric oxide formation by N°-nitro-L-arginine methyl ester failed to affect the capsaicin-evoked vasodilatation but 
abolished its amplification by interleukin-lß. These data indicate that the enhancement by interleukin-lß of the capsaicin-in-
duced hyperaemia involves thin afferent nerve fibres and depends on nitric mdde as esse'ntial intermediate. 
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1. lntroduction 
The cutaneous vasodilatation induced by topical ad-
ministration of capsaicin is to a large extent mediated 
by activation of thin afferent neiVe fibres and release 
of vasoactive peptides from their peripheral endings 
(Holzer, 1992). We have previously shown that the 
inflammatory cytokine interleukin-lß enhances the hy-
peraemia evoked by injection of capsaicin into the rat 
plantar hindpaw skin in a prostaglandin-dependent 
manner (Herbert and Holzer, 1994). Since the va-
sodilator effect of calcitonin gene-related peptide 
(CGRP), the major neuragenie mediator of the cap-
saicin-induced vasodilatation (Hughes and Brain, 1991; 
Brain et al., 1993), was not altered by interleukin-1ß it 
was concluded that the effect of the cytokine was 
brought about by sensitization of afferent neiVe end-
ings to capsaicin (Herbert and Holzer, 1994). 
This inference was further tested here by examining 
the effect of interleukin-1/3 in rats in which thin affer-
ent neurones bad been defunctionalized by systemic 
* Corresponding author. Tel. [0043] (316) 380-4310; Fax [0043] 
(316) 380-4323. 
0014-2999/94/$07.00 © 1994 Elsevier Science B.V. All rights reserved 
SSDI 0014-2~99(94)00307-S 
pretreatment with a neurotoxic dose of capsatcm 
(Holzer, 1991). Another aim of this study was to ex-
plore a possible participation of nitric oxide (NO) in 
the interleukin-lß-evoked augmentation of the va-
sodilator response to capsaicin. This possibility was 
envisaged from the findings that the effects of inter-
leukin-1ß on a variety of tissues and cells depend on 
the formation of NO as an intermediate messenger 
(Esplugues et al., 1993; Hogaboam et al., 1993; Inoue 
et al., 1993). Furthermore, it has been found that NO 
generated in the rat skin can give rise to afferent 
neiVe-mediated vasodilatation (Holzer and Jocic, 1994). 
2. Materials and methods 
The experiments, approved by the Austrian Ministry 
of Science and Research, were carried out with female 
Sprague-Dawley rats (Versuchstierzuchtanstalt Hirn-
berg, Austria) weighing 180-245 g. The rats were 
anaesthetized with phenobarbitone (250 mg kg- 1 i.p.), 
their trachea was cannulated, blood pressure moni-
tared continuously via a catheter in the right carotid 
artery, and rectal temperature maintained at 37.5-:38°C 
with a heating pad (Herbert and Holzer, 1994). Blood 
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flow in the plantar skin of each hindpaw was recorded 
with a calibrated Iaser Doppler flowmeter (Periflux 
PF3, Perimed, Sweden) as described previously (Her-
bert and Holzer, 1994), blood flow being expressed in 
dimensionless perfusion units (PU). 
The experimental procedure started after a 1 h 
equilibration period when interleukin-1ß (50 pg in 10 
Jtl fluid) was injected s.c. into the plantar side of the 
left paw while the right paw received vehicle (10 Jtl 
saline) only (time 0). Forty min later capsaicin (0.3 Jtg 
in 10 J ..d fluid) was injected into the same skin area 
(Herbert and Holzer, 1994). Cutaneous blood flow was 
measured at times 35, 45, 60 and 75 min (Herbert and 
Holzer, 1994). In study 1 this experimental protocol 
was tested on rats that bad been pretreated with a 
neurotoxic dose of capsaicin (125 mg kg- 1, s.c.) or its 
vehicle 2 weeks before the experiments. As described 
elsewhere (Holzer et al., 1992), the total dose of cap-
saicin was given in 4 injections over 2 days while the 
control rats received equal volumes of the vehicle. In 
study 2 the effects of N°-nitro-L-arginine methyl ester 
(15 mg kg- 1 given i.v. 30 min before the intraplantar 
injection of interleukin-1ß) and its enantiomer, N°-
nitro-o-arginine methyl ester, were compared with that 
of the vehicle (saline, 1 ml kg- 1 ). 
Human recombinant interleukin-1ß (Sigma, Deisen-
hofen, Germany), N°-nitro-L-arginine methyl ester and 
its enantiomer N°-nitro-o-arginine methyl ester 
(Bachern, Bubendorf, Switzerland) were dissolved in 
saline (0.15 M NaCI). Capsaicin (Serva, Heidelberg, 
Germany) was dissolved in absolute ethanol (30 mg 
ml- 1) and diluted with saline such that the solution 
used for intraplantar injection contained 0.1% (w jw) 
ethanol. The results are expressed as means ± S.E.M. 
of n rats. For statistical evaluation the PU values of 
the right and left paw, recorded 5 min after the cap-
saicin injection, were analyzed with the Wilcoxon 
matched-pairs signed rank test (two-tailed). Differ-
ences between different groups of rats were evaluated 
with the Mann-Whitney U-test. A value of P < 0.05 
was regarded as significant. 
3. Results 
Intraplantar injection of capsatcm to vehicle-pre-
treated rats increased cutaneous blood flow, a reaction 
that was significantly !arger in the paw treated with 
interleukin-lß than in the paw treated with saline (Fig. 
1). Pretreatment of rats with a neurotoxic dose of 
capsaicin did not significantly alter basal blood flow 
but inhibited the vasodilatation caused by acute intra-
plantar injection of capsaicin (Fig. 1). In the capsaicin-
pretreated rats, the hyperaemic response to intraplan-
tar injection of capsaicin (increment of cutaneous blood 
flow by 32 ± 6 PU, n = 6) was not larger, but rather 
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Fig. 1. Effect of interleukin-lß {IL-lß) to enhance the cutaneous 
hyperaemia evoked by capsaicin (Caps) in vehicle- and capsaicin-pre-
treated rats. Capsaicin (125 mg kg- 1 s.c.) or its vehicle were adminis-
tered 2 weeks before the experiments. At time 0 of the experiment, 
vehicle (10 iJ.l saline) was injected into the plantar side of the right 
paw whilst the left paw was treated with 50 pg IL-lß. Forty min later 
Caps (0.3 iJ.&) was injected into each paw. Cutaneous blood flow in 
the right (hatched columns) and left (filled columns) hindpaw was 
recorded by Iaser Doppler flowmetry and expressed in perfusion 
units (PU). The bars represent means ± S.E.M. of 6 rats. * P < 0.05 
versus respective values measured in the saline-t.reated paw (two-
tailed Wilcoxon matched-pairs signed rank test); * P < 0.05 versus 
respective values measured in the vehicle-pretreated rats (two-tailed 
Mann-Whitney V-test). 
smaller, than the response to intraplantar injection of 
saline (increment of cutaneous blood flow by 53 ± 4 
PU, n = 6). The effect of interleukin-lß to augment 
the capsaicin-induced vasodilatation was abolished by 
capsaicin pretreatment (Fig. 1). Mean arterial blood 
pressure in the capsaicin-pretreated rats (87 ± 7.5 mm 
Hg, n = 6) did not significantly (P = 0.084) differ from 
that in the vehicle-pretreated rats (102 ± 15.7 nun Hg, 
n = 6) as measured 5 min before the intraplantar injec-
tion of capsaicin. 
N°-nitro-L-arginine methyl ester, its enantiomer 
N°-nitro-o-arginine methyl ester and the vehicle, 
saline, were injected i.v. 30 min before the administra-
tion of interleukin-1ß. Neither N°-nitro-L-arginine 
methyl ester nor N°-nitro-o-arginine methyl ester al-
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tered basal blood flow in the plantar hindpaw skin to a 
significant extent when compared with the basal blood 
flow in saline-treated rats, although a trend towards a 
reduction was seen with N°-nitro-L-arginine methyl 
ester and a trend towards an increase was observed 
with N°-nitro-o-arginine methyl ester (Fig. 2). N°-
nitro-L-arginine methyl ester and N°-nitro-o-arginine 
methyl ester also failed to alter the hyperaemic re-
sponse to intraplantar injection of capsaicin in the paw 
treated with saline. N°-nitro-L-arginine methyl ester, 
however, prevented interleukin-1ß from enhancing the 
capsaicin-induced vasodilatation whereas N°-nitro-o-
arginine methylesterwas without effect (Fig. 2). N°-
nitro-L-arginine methyl ester led to an immediate rise 
of mean arterial blood pressure by 39 ± 6 mm Hg 
(n = 8) as measured 10 min post-injection, whereas 
mean arterial blood pressure rose by 11 ± 5 mm Hg 
(n = 8) only after the injection of N°-nitro-o-arginine 
rnethyl ester and did not change after i.v. injection of 
saline ( -4 ± 3 nun Hg, n = 8). N°-nitro-o-arginine 
methyl ester, however, led to a delayed increase in 
blood pressure. Thus, 5 min before the intraplantar 
injection of capsaicin (i.e., 65 min after the i.v. adminis-
tration of N°-nitro-L-arginine methyl ester, N°-nitro-
o-arginine methyl ester or saline) mean arterial blood 
pressure in the saline-treated rats was 98 ± 11 mm Hg 
(n = 8) compared with 113 ± 25 mm Hg (n = 8, not 
significantly different versus saline) in rats injected 
with N°-nitro-L-arginine methyl ester and 129 ± 26 
mm Hg (n = 8; P < 0.01 versus saline, not significantly 
different versus N°-nitro-L-arginine methyl ester) in 
rats injected with N°-nitro-o-arginine methyl ester. 
4. Discussion 
The present data confirm that interleukin-1ß en-
hances the capsaicin-induced increase of blood flow in 
the plantar skin of the rat hindpaw (Herbert and 
Holzer, 1994). Pretreatment of rats with a neurotoxic 
dose of capsaicin (Holzer, 1991) showed that the va-
sodilator response to capsaicin requires an intact in-
nervation of the skin by thin afferent neurones. The 
residual vasodilatation seen in capsaicin-pretreated rats 
is likely to be a reaction to the injection per se, since it 
was not higher than the vasodilatation caused by intra-
plantar injection of saline alone. These findings are 
consistent with the notion that the capsaicin-induced 
rise of cutaneous blood flow is mediated by stimulation 
of fine afferent nerve fibres (Holzer, 1992) and release 
of the vasodilator transmitter CGRP (Hughes and 
Brain, 1991; Brain et al., 1993). Hence, the absence of 
any effect of interleukin-lß in capsaicin-pretreated 
rats implies that the cytokine augments the neurogenic 
component in the vasodilator response to capsaicin by 
sensitizing afferent nerve fibres to noxious stimuli. This 
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Fig. 2. Effect of interleukin·lß (IL-lß) to enhance the cutaneous 
hyperaemia evoked by capsaicin (Caps) in rats treated with saline, 
N°-nitro-L-arginine methyl ester (L-NAME) or N°-nitro-n-arginine 
methyl ester (n-NAME). Saline (1 ml kg- 1), L-NAME and n-NAME 
(each 15 mg kg- 1) were injected i.v. 30 min before the administra-
tion of IL-lß. At time 0 of the experiment, vehicle (10 J.Ll saline) was 
injected into the plantar side of the right paw whilst the left paw was 
treated with 50 pg IL-lß. Forty min later Caps (0.3~J.g) was injected 
into each paw. Cutaneous blood flow in the right (hatched columns) 
and left (filled columns) hindpaw was recorded by Iaser Doppler 
flowmetry and expressed in perfusion units (PU). The bars represent 
means ± S.E.M. of 8 rats. * P < 0.05 versus respective values mea-
sured in the saline-treated paw (two-tailed Wilcoxon matched-pairs 
signed rank test). 
inference is further supported by the inability of inter-
leukin-1ß to enhance the vasodilator response to 
CGRP, which rules out the possibility that the cytokine 
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acts by increasing the sensitivity of blood vessels to 
vasodiJator mediators (Herbert and Holzer, 1994). 
lmportant for the understanding as to how inter-
leukin-1ß sensitizes afferent nerve fibres is the finding 
that the cytokine-induced augmentation of the hyper-
aemic response to capsaicin depended on the forma-
tion of NO as an intermediate messenger. The involve-
ment of NO was demonstrated with the NO synthase 
inhibitor N°-nitro-L-arginine methyl ester ( Gardiner et 
al., 1990; Rees et al., 1990) which prevented the sensi-
tizing action of interleukin-1 ß in an enantiomer-specific 
manner. N°-nitro-o-arginine methyl ester, which is 
said tobe inactive on the NO synthase (Gardiner et al., 
1990; Rees et al., 1990), did not interfere with the 
action of interleukin-1ß but led to a delayed increase 
in blood pressure that did not differ from the prompt 
rise of blood pressure caused by N°-nitro-L-arginine 
methyl ester. It follows that the hypertension caused by 
N°-nitro-L-arginine methyl ester cannot be held re-
sponsible for the concomitant Suppression of the ability 
of interleukin-1ß to facilitate the vasodilator response 
to capsaicin. The activity of N°-nitro-o-arginine methyl 
ester to elevate blood pressure, which has been noted 
previously (Holzer et al., 1993), is not understood at 
present. N°-nitro-L-arginine methyl ester was given 
systemically since this route of administration did not 
significantly diminish cutaneous blood flow, whereas 
local application of the drug has been observed to 
, reduce skin blood flow to a significant extent (Holzer 
and Jocic, 1994). The use of s.c. N°-nitro-L-arginine 
methyl ester was regarded as impractible, therefore, 
given that local N°-nitro-L-arginine methyl ester could 
inhibit vasodilator responses solely by virtue of its 
vasoconstrictor effect. Such a functional antagonism 
might be responsible for the inhibitory effect of topical 
N°-nitro-L-arginine methyl ester on capsaicin-induced 
vasodilatation (Brain et al., 1993), an effect that was 
not observed after i.v. administration of the drug. The 
effectiveness of N°-nitro-L-arginine methyl ester (15 
mg kg -l i.v.) as a blocker of NO synthase has been 
established in a previous study (Holzer et al., 1993). 
The participation of NO in the action of interleukin-
1 ß to augment the capsaicin-evoked rise of cutaneous 
blood flow needs to be seen in context with the re-
ported involvement of cyclooxygenase products such as 
prostaglandins in this action of the cytokine (Herbert 
and Holzer, 1994). The question arises as to cellular 
sources and the sequential mechanism of action of NO 
and prostaglandins. As both autacoids are shortlived 
biological messengers it has to be assumed that NO 
and cyclooxygenase products are generated by inter-
leukin-1ß in close vicinity of, or even within, afferent 
nerve endings so that they can contribute to the sensiti-
zation process. Two cellular systems may play a partic-
ularly important role in the action of interleukin-1ß to 
augment the hyperaemic response to capsaicin. Firstly, 
NO is produced by rat mast cells in response to inter-
leukin-1ß (Hogaboam et al., 1993) within a time frame 
of 30 min and influences the release of other inflarn-
matory mediators (Hogaboam et al., 1993). As mast 
cells are often juxtaposed to blood vessels and afferent 
nerve endings (Holzer, 1992) it could be hypothesized 
that interleukin-lß acts on these cells to stimulate the 
sequential formation of NO and prostaglandins which, 
in turn, contribute to the sensitization of afferent nerve 
endings. In addition, NO generated in the rat skin can 
by itself give rise to afferent nerve-mediated vasodila-
tation (Holzer and Jocic, 1994). Secondly, interleukin-
1ß has been shown to stimulate the consecutive forma-
tion of NO and prostagtandin E 2 in vascular smooth 
muscle cells (lnoue et al., 1993). lt is not clear, how-
ever, whether this effect of the c}'tokine has a bearing 
on the current findings because the cytokine's effect on 
vascular smooth muscle cells depends on the induction 
of NO synthase and requires several hours to develop 
(lnoue et al., 1993). 
In conclusion, interleukin-lß has been shown to 
augment the cutaneous hyperaemic response to cap-
saicin by a sensitizing action on afferent nerve fibres, 
an action which involves NO. These findings empha-
size a close interaction between immune mediators 
(interleukin-1ß), intermediate messengers (NO, prosta-
glandins) and neuragenie factors (CGRP) in the con-
trol of vascular functions and inflammatory processes 
in the skin. 
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